Two panels of biomarkers distinguishing psoriatic arthritis from osteroarthritis were suggested: (a) COMP, resistin, NGF (nerve growth factor), MCP-1 (monocyte chemoattractant protein-1) [44] and (b) COMP, aggrecan [46]. The gene discussed is CCL2; the disease is psoriatic arthritis.